1380291-34-8 Usage
Description
3-(3-oxocyclobutyl)propanoic acid is a chemical compound with the molecular formula C9H12O3. It is a cyclic ketone derivative featuring a cyclobutane ring and a propanoic acid group. 3-(3-oxocyclobutyl)propanoic acid is recognized for its unique structure and properties, making it a valuable chemical in various industries.
Uses
Used in Organic Synthesis:
3-(3-oxocyclobutyl)propanoic acid is used as a building block in organic synthesis for the creation of various bioactive compounds. Its cyclobutane ring and propanoic acid group contribute to the structural diversity and functional groups available in synthesized products.
Used in Pharmaceutical Research:
In pharmaceutical research, 3-(3-oxocyclobutyl)propanoic acid serves as a key component in the synthesis of new drugs. Its potential biological activity and unique structure make it a promising candidate for the development of innovative pharmaceuticals.
Used in the Production of Pharmaceuticals:
3-(3-oxocyclobutyl)propanoic acid is utilized as a reagent in the manufacturing process of pharmaceuticals. Its involvement in the synthesis of bioactive compounds aids in the production of effective and targeted medications.
Used in Agrochemical Production:
3-(3-oxocyclobutyl)propanoic acid also finds application in the agrochemical industry, where it is used as a reagent in the production of various agrochemicals. Its role in creating bioactive compounds contributes to the development of effective agricultural products.
Check Digit Verification of cas no
The CAS Registry Mumber 1380291-34-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,0,2,9 and 1 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1380291-34:
(9*1)+(8*3)+(7*8)+(6*0)+(5*2)+(4*9)+(3*1)+(2*3)+(1*4)=148
148 % 10 = 8
So 1380291-34-8 is a valid CAS Registry Number.
1380291-34-8Relevant articles and documents
METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS
-
Paragraph 0625; 0626; 0627, (2014/10/04)
The present invention provides an efficient process for the synthesis of (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H- benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofiiran-3,4-diol and hydrates thereof and methods for treating disorders in which DOTl -mediated protein methylation plays a part, such as cancer and neurological disorders, by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also provides novel crystalline forms of (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)- 5 -(((( 1 r,3 S)-3 -(2-(5 -(tert-butyl)- 1 H-benzo[d] imidazol-2- yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofuran-3,4-diol and hydrates thereof (Form A, Form B, and Form C), characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, as well as a unique crystalline structure.
